Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
International Journal of Hematology
|
September 1, 2020
The clonal evolution during long-term clinical course of multiple myeloma
Yuko Mishima, Yuji Mishima, Yuko Shirouchi, et al.
Haematologica
|
September 28, 2014
Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma
Hideaki Nitta, Yasuhito Terui, Masahiro Yokoyama, et al.
Leukemia & Lymphoma
|
March 22, 2021
Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with <i>de novo</i> diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma
Hideki Uryu, Yuko Mishima, Naoko Tsuyama, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 6, 2003
Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse
Takashi Moriguchi, Hozumi Motohashi, Tomonori Hosoya, et al.
ISRN Oncology
|
May 22, 2013
Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan
Masahiro Yokoyama, Yasuhito Terui, Kengo Takeuchi, et al.
International Journal of Hematology
|
November 2, 2019
Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis
Kazuhito Suzuki, Nobuhiro Tsukada, Noriko Nishimura, et al.
Leukemia & Lymphoma
|
November 1, 2011
High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone
Kazuhito Suzuki, Yasuhito Terui, Kenji Nakano, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|
February 23, 2010
[Case of spuriously high level of squamous cell carcinoma antigen in patient without carcinoma--HPLC and ultrafiltration are useful to analyze the true value]
Yutaka Komiyama, Akiko Ikuta, Takae Ozaki, et al.
Annals of Hematology
|
February 21, 2022
Durable response of therapy-related MDS/AML with concomitant Waldenström's macroglobulinemia treated with venetoclax and azacitidine
Mitsuhito Hirano, Mikako Tamba, Norihito Inoue, et al.
Proteomics. Clinical Applications
|
December 8, 2010
An application of the 2-nitrobenzenesulfenyl method to proteomic profiling of human colorectal carcinoma: A novel approach for biomarker discovery
Makoto Watanabe, Ichiro Takemasa, Naomasa Kawaguchi, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
International Journal of Hematology
|
September 1, 2020
The clonal evolution during long-term clinical course of multiple myeloma
Yuko Mishima, Yuji Mishima, Yuko Shirouchi, et al.
Haematologica
|
September 28, 2014
Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma
Hideaki Nitta, Yasuhito Terui, Masahiro Yokoyama, et al.
Leukemia & Lymphoma
|
March 22, 2021
Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with <i>de novo</i> diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma
Hideki Uryu, Yuko Mishima, Naoko Tsuyama, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 6, 2003
Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse
Takashi Moriguchi, Hozumi Motohashi, Tomonori Hosoya, et al.
ISRN Oncology
|
May 22, 2013
Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan
Masahiro Yokoyama, Yasuhito Terui, Kengo Takeuchi, et al.
International Journal of Hematology
|
November 2, 2019
Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis
Kazuhito Suzuki, Nobuhiro Tsukada, Noriko Nishimura, et al.
Leukemia & Lymphoma
|
November 1, 2011
High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone
Kazuhito Suzuki, Yasuhito Terui, Kenji Nakano, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|
February 23, 2010
[Case of spuriously high level of squamous cell carcinoma antigen in patient without carcinoma--HPLC and ultrafiltration are useful to analyze the true value]
Yutaka Komiyama, Akiko Ikuta, Takae Ozaki, et al.
Annals of Hematology
|
February 21, 2022
Durable response of therapy-related MDS/AML with concomitant Waldenström's macroglobulinemia treated with venetoclax and azacitidine
Mitsuhito Hirano, Mikako Tamba, Norihito Inoue, et al.
Proteomics. Clinical Applications
|
December 8, 2010
An application of the 2-nitrobenzenesulfenyl method to proteomic profiling of human colorectal carcinoma: A novel approach for biomarker discovery
Makoto Watanabe, Ichiro Takemasa, Naomasa Kawaguchi, et al.
Page
of 9